Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Kelly Doran to Virulence

This is a "connection" page, showing publications Kelly Doran has written about Virulence.

 
Connection Strength
 
 
 
3.933
 
  1. Spencer BL, Tak U, Mendonça JC, Nagao PE, Niederweis M, Doran KS. A type VII secretion system in Group B Streptococcus mediates cytotoxicity and virulence. PLoS Pathog. 2021 12; 17(12):e1010121.
    View in: PubMed
    Score: 0.651
  2. Deng L, Mu R, Weston TA, Spencer BL, Liles RP, Doran KS. Characterization of a Two-Component System Transcriptional Regulator, LtdR, That Impacts Group B Streptococcal Colonization and Disease. Infect Immun. 2018 07; 86(7).
    View in: PubMed
    Score: 0.512
  3. Mu R, Cutting AS, Del Rosario Y, Villarino N, Stewart L, Weston TA, Patras KA, Doran KS. Identification of CiaR Regulated Genes That Promote Group B Streptococcal Virulence and Interaction with Brain Endothelial Cells. PLoS One. 2016; 11(4):e0153891.
    View in: PubMed
    Score: 0.441
  4. Keogh RA, Job AM, Joyce LR, Akbari MS, Nguyen A, Kavanaugh JS, Horswill AR, Doran KS. The diabetic wound microenvironment drives emergence and maintenance of CovRS variants in group B Streptococcus. Infect Immun. 2026 Jul 14; 94(7):e0009926.
    View in: PubMed
    Score: 0.223
  5. Cohen S, Crossen AJ, Jensen O, Neely MN, Le Doare K, Nobbs AH, Ost KS, Doran KS. A fungal pathobiont promotes Streptococcus vaginal persistence and pathogenesis through physical and metabolic interactions. Cell Host Microbe. 2026 Jun 10; 34(6):1118-1134.e7.
    View in: PubMed
    Score: 0.221
  6. Akbari MS, Joyce LR, Spencer BL, Brady A, McIver KS, Doran KS. Identification of glyoxalase A in group B Streptococcus and its contribution to methylglyoxal tolerance and virulence. Infect Immun. 2025 04 08; 93(4):e0054024.
    View in: PubMed
    Score: 0.204
  7. Joyce LR, Kim S, Spencer BL, Christensen PM, Palmer KL, Guan Z, Siegenthaler JA, Doran KS. Streptococcus agalactiae glycolipids promote virulence by thwarting immune cell clearance. Sci Adv. 2024 05 31; 10(22):eadn7848.
    View in: PubMed
    Score: 0.193
  8. Spencer BL, Job AM, Robertson CM, Hameed ZA, Serchejian C, Wiafe-Kwakye CS, Mendonça JC, Apolonio MA, Nagao PE, Neely MN, Korotkova N, Korotkov KV, Patras KA, Doran KS. Heterogeneity of the group B streptococcal type VII secretion system and influence on colonization of the female genital tract. Mol Microbiol. 2023 08; 120(2):258-275.
    View in: PubMed
    Score: 0.181
  9. Joyce LR, Doran KS. Gram-positive bacterial membrane lipids at the host-pathogen interface. PLoS Pathog. 2023 01; 19(1):e1011026.
    View in: PubMed
    Score: 0.175
  10. Manzer HS, Villarreal RI, Doran KS. Targeting the BspC-vimentin interaction to develop anti-virulence therapies during Group B streptococcal meningitis. PLoS Pathog. 2022 03; 18(3):e1010397.
    View in: PubMed
    Score: 0.166
  11. Burcham LR, Le Breton Y, Radin JN, Spencer BL, Deng L, Hiron A, Ransom MR, Mendonça JDC, Belew AT, El-Sayed NM, McIver KS, Kehl-Fie TE, Doran KS. Identification of Zinc-Dependent Mechanisms Used by Group B Streptococcus To Overcome Calprotectin-Mediated Stress. mBio. 2020 11 10; 11(6).
    View in: PubMed
    Score: 0.151
  12. Burcham LR, Spencer BL, Keeler LR, Runft DL, Patras KA, Neely MN, Doran KS. Determinants of Group B streptococcal virulence potential amongst vaginal clinical isolates from pregnant women. PLoS One. 2019; 14(12):e0226699.
    View in: PubMed
    Score: 0.142
  13. Kim BJ, Hancock BM, Del Cid N, Bermudez A, Traver D, Doran KS. Streptococcus agalactiae infection in zebrafish larvae. Microb Pathog. 2015 Feb; 79:57-60.
    View in: PubMed
    Score: 0.101
  14. Burnside K, Lembo A, Harrell MI, Gurney M, Xue L, BinhTran NT, Connelly JE, Jewell KA, Schmidt BZ, de Los Reyes M, Tao WA, Doran KS, Rajagopal L. Serine/threonine phosphatase Stp1 mediates post-transcriptional regulation of hemolysin, autolysis, and virulence of group B Streptococcus. J Biol Chem. 2011 Dec 23; 286(51):44197-44210.
    View in: PubMed
    Score: 0.081
  15. van Sorge NM, Quach D, Gurney MA, Sullam PM, Nizet V, Doran KS. The group B streptococcal serine-rich repeat 1 glycoprotein mediates penetration of the blood-brain barrier. J Infect Dis. 2009 May 15; 199(10):1479-87.
    View in: PubMed
    Score: 0.068
  16. Quach D, van Sorge NM, Kristian SA, Bryan JD, Shelver DW, Doran KS. The CiaR response regulator in group B Streptococcus promotes intracellular survival and resistance to innate immune defenses. J Bacteriol. 2009 Apr; 191(7):2023-32.
    View in: PubMed
    Score: 0.066
  17. Maisey HC, Quach D, Hensler ME, Liu GY, Gallo RL, Nizet V, Doran KS. A group B streptococcal pilus protein promotes phagocyte resistance and systemic virulence. FASEB J. 2008 Jun; 22(6):1715-24.
    View in: PubMed
    Score: 0.062
  18. Hensler ME, Quach D, Hsieh CJ, Doran KS, Nizet V. CAMP factor is not essential for systemic virulence of Group B Streptococcus. Microb Pathog. 2008 Jan; 44(1):84-8.
    View in: PubMed
    Score: 0.060
  19. Alves J, Crestani C, Marroquin SM, Johnston ABE, Ring N, Bowen C, Reglinski M, Doran KS, Zadoks RN, Lynskey NN. Acquisition of a novel restriction modification system regulates genetic flux and gene expression in the hypervirulent and globally disseminated CC17 lineage of group B Streptococcus. Nucleic Acids Res. 2026 Jul 03; 54(13).
    View in: PubMed
    Score: 0.056
  20. Doran KS, Nizet V. Molecular pathogenesis of neonatal group B streptococcal infection: no longer in its infancy. Mol Microbiol. 2004 Oct; 54(1):23-31.
    View in: PubMed
    Score: 0.049
  21. Lannes-Costa PS, Baraúna RA, Ramos JN, Veras JFC, Conceição MVR, Vieira VV, de Mattos-Guaraldi AL, Ramos RTJ, Doran KS, Silva A, Nagao PE. Comparative genomic analysis and identification of pathogenicity islands of hypervirulent ST-17 Streptococcus agalactiae Brazilian strain. Infect Genet Evol. 2020 06; 80:104195.
    View in: PubMed
    Score: 0.036
  22. Gendrin C, Lembo A, Whidbey C, Burnside K, Berry J, Ngo L, Banerjee A, Xue L, Arrington J, Doran KS, Tao WA, Rajagopal L. The sensor histidine kinase RgfC affects group B streptococcal virulence factor expression independent of its response regulator RgfA. Infect Immun. 2015 Mar; 83(3):1078-88.
    View in: PubMed
    Score: 0.025
  23. Faralla C, Metruccio MM, De Chiara M, Mu R, Patras KA, Muzzi A, Grandi G, Margarit I, Doran KS, Janulczyk R. Analysis of two-component systems in group B Streptococcus shows that RgfAC and the novel FspSR modulate virulence and bacterial fitness. mBio. 2014 May 20; 5(3):e00870-14.
    View in: PubMed
    Score: 0.024
  24. Maisey HC, Doran KS, Nizet V. Recent advances in understanding the molecular basis of group B Streptococcus virulence. Expert Rev Mol Med. 2008 Sep 22; 10:e27.
    View in: PubMed
    Score: 0.016
  25. Kwinn LA, Khosravi A, Aziz RK, Timmer AM, Doran KS, Kotb M, Nizet V. Genetic characterization and virulence role of the RALP3/LSA locus upstream of the streptolysin s operon in invasive M1T1 Group A Streptococcus. J Bacteriol. 2007 Feb; 189(4):1322-9.
    View in: PubMed
    Score: 0.014
  26. Liu GY, Doran KS, Lawrence T, Turkson N, Puliti M, Tissi L, Nizet V. Sword and shield: linked group B streptococcal beta-hemolysin/cytolysin and carotenoid pigment function to subvert host phagocyte defense. Proc Natl Acad Sci U S A. 2004 Oct 05; 101(40):14491-6.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)